Stockscreener 앱 받기
1.98
21.43%
-0.54
시간 외 거래:
2.03
0.05
+2.53%
전일 마감가:
$2.52
열려 있는:
$2.52
하루 거래량:
1.25M
Relative Volume:
0.79
시가총액:
$1.38M
수익:
-
순이익/손실:
$-14.93M
주가수익비율:
-0.00744
EPS:
-266.137
순현금흐름:
$-15.87M
1주 성능:
-75.48%
1개월 성능:
-80.08%
6개월 성능:
-79.16%
1년 성능:
-91.45%
1일 변동 폭
$1.89
$2.54
1주일 범위
$1.89
$8.40
52주 변동 폭
$1.89
$66.33
트랜스코드 테라 Stock (RNAZ) Company Profile
명칭
Transcode Therapeutics Inc
전화
857-301-6857
주소
6 LIBERTY SQUARE, BOSTON
RNAZ을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RNAZ
Transcode Therapeutics Inc
|
1.98 | 1.38M | 0 | -14.93M | -15.87M | -266.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
479.79 | 123.21B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
698.74 | 76.39B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
624.67 | 37.96B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.75 | 31.94B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
271.80 | 29.00B | 3.32B | -860.46M | -1.04B | -8.32 |
트랜스코드 테라 주식(RNAZ)의 최신 뉴스
Transcode Therapeutics stock hits 52-week low at $2.62 By Investing.com - Investing.com South Africa
Transcode Therapeutics stock hits 52-week low at $2.62 - Investing.com
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - Investing.com India
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.37% - Investing.com
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - Investing.com UK
TransCode Shareholders Green-Light Warrant Changes: What This Means for RNAZ's Financial Future - StockTitan
Stock market news: China SXT Pharmaceuticals -92.51%, TransCode Therapeutics -37.91% among biggest losers during midday trading - Business Upturn
Learn to Evaluate (RNAZ) using the Charts - Stock Traders Daily
TransCode reports positive phase 1 trial progress for cancer therapy - MSN
(RNAZ) Technical Data - Stock Traders Daily
Clinical Trials News Live Feed - StockTitan
RNAZ’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle
The -45.19% Simple Moving Average of TransCode Therapeutics Inc’s (RNAZ) Stock in the Past 200 Days - The News Heater
The Impact of Market Fluctuations on ChargePoint Holdings Inc’s (CHPT) Stock - The News Heater
Market Analysts see Helmerich & Payne, Inc [HP] falling to $39. Time to buy? - The DBT News
Wag Group Co [PET] Revenue clocked in at $76.75 million, up 36.38% YTD: What’s Next? - The DBT News
Wall Street Analyst Reiterated Gamestop Corporation [GME]. What else is Wall St. saying - The DBT News
Shoals Technologies Group Inc [SHLS] Stock trading around $4.60 per share: What’s Next? - The DBT News
Ensysce Biosciences (NASDAQ:ENSC) Stock Quotes, Forecast and News Summary - Benzinga
Cronos Group Inc [CRON] fell 0.00% so far this year. What now? - The DBT News
Northern Dynasty Minerals Ltd [NAK] is 26.40% higher this YTD. Is it still time to buy? - The DBT News
For Coupang Inc [CPNG], Analyst sees a rise to $30. What next? - The DBT News
Market Analysts see BBB Foods Inc [TBBB] gaining to $32. Time to buy? - The DBT News
why Borr Drilling Ltd [BORR] is a Good Choice for Investors After New Price Target of $5.23 - The DBT News
American Superconductor Corp [AMSC] Stock trading around $34.24 per share: What’s Next? - The DBT News
Callan JMB Inc [CJMB] gain 54.15% so far this year. What now? - The DBT News
Wall Street Analyst Resumed Equillium Inc [EQ]. What else is Wall St. saying - The DBT News
why Silexion Therapeutics Corp [SLXN] is a Good Choice for Investors After New Price Target of $9.00 - The DBT News
SNDL Inc [SNDL] Is Currently 3.76 above its 200 Period Moving Avg: What Does This Mean? - The DBT News
Envista Holdings Corp [NVST] moved up 5.93: Why It’s Important - The DBT News
2 Top Fintech Stocks to Buy in February - The Globe and Mail
Wall Street Analyst Resumed Lilly[Eli] & Co [LLY]. What else is Wall St. saying - The DBT News
Health In Tech Inc [HIT] Revenue clocked in at $19.80 million, down -0.84% YTD: What’s Next? - The DBT News
AEON Biopharma Inc [AEON] Stock trading around $0.14 per share: What’s Next? - The DBT News
Stocks of TransCode Therapeutics Inc (RNAZ) are poised to climb above their peers - SETE News
TransCode Therapeutics (NASDAQ:RNAZ) Receives Buy Rating from HC Wainwright - Armenian Reporter
Insider Buying: Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Director Purchases $103,200.00 in Stock - Armenian Reporter
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Stock market today: Lipella Pharmaceuticals +99.22%, Digital Turbine +68.90% among top gainers in early trading - Business Upturn
Transcode Therapeutics completes Cohort 3 dosing in Phase 1 trial of TTX-MC138 - TipRanks
TransCode reports positive phase 1 trial progress for cancer therapy By Investing.com - Investing.com UK
TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing with Lead Candidate in Phase 1 Clinical Trial - PR Newswire
TransCode Therapeutics, Inc. Announces Adjournment of Special Meeting and Information for Adjourned Special Meeting - Longview News-Journal
How Is The Market Feeling About TransCode Therapeutics? - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Stock market news: TransCode Therapeutics +133.97%, Diginex +27.49% among top gainers during mid day trading - Business Upturn
Are Investors Keen On Selling Holdings In GSK Plc ADR (NYSE: GSK)? - Stocks Register
Dow Inc (NYSE: DOW) Is A Buzzing Hot Stock - Stocks Register
Stock market today: Sentage Holdings +70.79%, Planet Image International +64.29% among top gainers in early trading - Business Upturn
TransCode Therapeutics Shares Are Surging Today: What's Going On? - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
트랜스코드 테라 (RNAZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.22%
0.81%
자본화:
|
볼륨(24시간):